These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11223851)

  • 21. COL4A5 splice site mutation and alpha 5(IV) collagen mRNA in Alport syndrome.
    Netzer KO; Pullig O; Frei U; Zhou J; Tryggvason K; Weber M
    Kidney Int; 1993 Feb; 43(2):486-92. PubMed ID: 8441246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of large deletion mutations in the COL4A5 gene of female Alport syndrome patients.
    Nozu K; Przybyslaw Krol R; Ohtsuka Y; Nakanishi K; Yoshikawa N; Nozu Y; Kaito H; Kanda K; Hashimura Y; Hamasaki Y; Iijima K; Matsuo M
    Pediatr Nephrol; 2008 Nov; 23(11):2085-90. PubMed ID: 18584212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MLPA and cDNA analysis improves COL4A5 mutation detection in X-linked Alport syndrome.
    Hertz JM; Juncker I; Marcussen N
    Clin Genet; 2008 Dec; 74(6):522-30. PubMed ID: 18616531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Somatic mosaicism for a mutation of the COL4A5 gene is a cause of mild phenotype male Alport syndrome.
    Krol RP; Nozu K; Nakanishi K; Iijima K; Takeshima Y; Fu XJ; Nozu Y; Kaito H; Kanda K; Matsuo M; Yoshikawa N
    Nephrol Dial Transplant; 2008 Aug; 23(8):2525-30. PubMed ID: 18332068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of mutations in COL4A5 in patients with Alport syndrome.
    Plant KE; Green PM; Vetrie D; Flinter FA
    Hum Mutat; 1999; 13(2):124-32. PubMed ID: 10094548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unusual deep intronic mutations in the COL4A5 gene cause X linked Alport syndrome.
    King K; Flinter FA; Nihalani V; Green PM
    Hum Genet; 2002 Dec; 111(6):548-54. PubMed ID: 12436246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant splicing of the COL4A5 gene in patients with Alport syndrome.
    Lemmink HH; Kluijtmans LA; Brunner HG; Schröder CH; Knebelmann B; Jelínková E; van Oost BA; Monnens LA; Smeets HJ
    Hum Mol Genet; 1994 Feb; 3(2):317-22. PubMed ID: 8004101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A single-base mutation in exon 31 converting glycine 852 to arginine in the collagenous domain in an Alport syndrome patient.
    Kawai S; Nomura S; Harano T; Harano K; Fukushima T; Wago M; Shimizu B; Osawa G
    Nephron; 1996; 74(2):333-6. PubMed ID: 8893151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations in the codon for a conserved arginine-1563 in the COL4A5 collagen gene in Alport syndrome.
    Zhou J; Gregory MC; Hertz JM; Barker DF; Atkin C; Spencer ES; Tryggvason K
    Kidney Int; 1993 Mar; 43(3):722-9. PubMed ID: 8455372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alport syndrome caused by inversion of a 21 Mb fragment of the long arm of the X-chromosome comprising exon 9 through 51 of the COL4A5 gene.
    Hertz JM; Persson U; Juncker I; Segelmark M
    Hum Genet; 2005 Oct; 118(1):23-8. PubMed ID: 16133187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unequal homologous crossing over resulting in duplication of 36 base pairs within exon 47 of the COL4A5 gene in a family with Alport syndrome.
    Hämäläinen ER; Renieri A; Pecoraro C; De Marchi M; Pihlajaniemi T
    Hum Mutat; 1996; 8(3):265-9. PubMed ID: 8889587
    [No Abstract]   [Full Text] [Related]  

  • 32. A large tandem duplication within the COL4A5 gene is responsible for the high prevalence of Alport syndrome in French Polynesia.
    Arrondel C; Deschênes G; Le Meur Y; Viau A; Cordonnier C; Fournier A; Amadeo S; Gubler MC; Antignac C; Heidet L
    Kidney Int; 2004 Jun; 65(6):2030-40. PubMed ID: 15149316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deletions of the COL4A5 gene in patients with Alport syndrome.
    Netzer KO; Renders L; Zhou J; Pullig O; Tryggvason K; Weber M
    Kidney Int; 1992 Dec; 42(6):1336-44. PubMed ID: 1474765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional assessment of a novel COL4A5 splice region variant and immunostaining of plucked hair follicles as an alternative method of diagnosis in X-linked Alport syndrome.
    Malone AF; Funk SD; Alhamad T; Miner JH
    Pediatr Nephrol; 2017 Jun; 32(6):997-1003. PubMed ID: 28013382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deletions of both alpha 5(IV) and alpha 6(IV) collagen genes in Alport syndrome and in Alport syndrome associated with smooth muscle tumours.
    Heidet L; Dahan K; Zhou J; Xu Z; Cochat P; Gould JD; Leppig KA; Proesmans W; Guyot C; Guillot M
    Hum Mol Genet; 1995 Jan; 4(1):99-108. PubMed ID: 7711741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spectrum of COL4A5 mutations in Finnish Alport syndrome patients.
    Martin P; Heiskari N; Pajari H; Grönhagen-Riska C; Kääriäinen H; Koskimies O; Tryggvason K
    Hum Mutat; 2000 Jun; 15(6):579. PubMed ID: 10862091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and genetic mapping of X chromosome in the X-linked dominant inherited Alport's syndrome.
    Dai Y; Huang Y; He X; Wang S; Huang R; Tang M; Hu C
    Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):767-74. PubMed ID: 18711293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutation in the alpha 5(IV) collagen chain in juvenile-onset Alport syndrome without hearing loss or ocular lesions: detection by denaturing gradient gel electrophoresis of a PCR product.
    Zhou J; Hertz JM; Tryggvason K
    Am J Hum Genet; 1992 Jun; 50(6):1291-300. PubMed ID: 1598909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of psoralen-coupled nucleotide primers for screening of COL4A5 mutations in Alport syndrome.
    Netzer KO; Seibold S; Gross O; Lambrecht R; Weber M
    Kidney Int; 1996 Oct; 50(4):1363-7. PubMed ID: 8887300
    [No Abstract]   [Full Text] [Related]  

  • 40. Topoisomerase I and II consensus sequences in a 17-kb deletion junction of the COL4A5 and COL4A6 genes and immunohistochemical analysis of esophageal leiomyomatosis associated with Alport syndrome.
    Ueki Y; Naito I; Oohashi T; Sugimoto M; Seki T; Yoshioka H; Sado Y; Sato H; Sawai T; Sasaki F; Matsuoka M; Fukuda S; Ninomiya Y
    Am J Hum Genet; 1998 Feb; 62(2):253-61. PubMed ID: 9463311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.